Use of medication during pregnancy and risk of childhood leukemia (Canada)

Cancer Causes and Control

Volumn 15, Issue 9, 2004, Pages 931-937

  Shaw, Amanda K ^a   Infante Rivard, Claire ^b   Morrison, Howard I ^a  

^a HEALTH CANADA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

child; leukemia; maternal medication; risk

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; CENTRAL DEPRESSANT AGENT; HORMONE; ILLICIT DRUG; IMMUNOSUPPRESSIVE AGENT; ORAL CONTRACEPTIVE AGENT; VITAMIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANADA; CANCER RISK; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; HIGH RISK POPULATION; HUMAN; INFANT; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY; RISK ASSESSMENT; TERATOGENICITY;

ADOLESCENT; ADULT; CANADA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERVIEWS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MATERNAL EXPOSURE; PHARMACEUTICAL PREPARATIONS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; TERATOGENS;

EID: 10844274668     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10552-004-2230-6     Document Type: Article

References (50)

1. National Cancer Institute of Canada (2003) Canadian Cancer Statistics 2003. Toronto.
2. Little J (1999) Epidemiology of Childhood Cancer. Lyon, France: International Agency for Research on Cancer, IARC Scientific Publications.
3. Ries L, Smith M, Gurney J, et al. (1999) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. [NIH Pub.No. 99-4649]. Bethesda, MD: National Cancer Institute, SEER Program.
4. Darby SC, Roman E (1996) Links in childhood leukaemia. Nature 382: 303-304.
5. Greaves M (2002) Childhood leukaemia. BMJ 324: 283-287.
6. Gale KB, Ford AM, Repp R, et al. (1997) Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 94: 13950-13954.
7. Wiemels JL, Cazzaniga G, Daniotti M, et al. (1999) Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354: 1499-1503.
8. McHale CM, Smith MT (2004) Prenatal origin of chromosomal translocations in acute childhood leukemia: implications and future directions. Am J Hematol 75: 254-257.
9. Hakkola J, Pelkonen O, Pasanen M, Raunio H (1998) Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity. Crit Rev Toxicol 28: 35-72.
10. Mihaly GW, Morgan DJ (1983) Placental drug transfer: effects of gestational age and species. Pharmacol Ther 23: 253-266.
11. Wells PG, Winn LM (1996) Biochemical toxicology of chemical teratogenesis. Crit Rev Biochem Mol Biol 31: 1-40.
12. Wells PG, Kim PM, Laposa RR, Nicol CJ, Parman T, Winn LM (1997) Oxidative damage in chemical teratogenesis. Mutat Res 396: 65-78.
13. Greenwald P, Barlow JJ, Nasca PC, Burnett WS (1971) Vaginal cancer after maternal treatment with synthetic estrogens. N Engl J Med 285: 390-392.
14. Herbst AL, Ulfelder H, Poskanzer DC (1971) Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284: 878-881.
15. Cocco P, Rapallo M, Targhetta R, Biddau PF, Fadda D (1996) Analysis of risk factors in a cluster of childhood acute lymphoblastic leukemia. Arch Environ Health 51: 242-244.
16. McWhirter WR, Chant DC (1990) A study of antenatal factors associated with the occurrence of childhood leukemia. Cancer Therapy Contr 1: 133-139.
17. Wen W, Shu XO, Potter JD, et al. (2002) Parental medication use and risk of childhood acute lymphoblastic leukemia. Cancer 95: 1786-1794.
18. McKinney PA, Juszczak E, Findlay E, Smith K, Thomson CS (1999) Pre- and perinatal risk factors for childhood leukaemia and other malignancies: a Scottish case control study. Br J Cancer 80: 1844-1851.
19. Infante-Rivard C, Fortier I, Olson E (2000) Markers of infection, breast-feeding and childhood acute lymphoblastic leukaemia. Br J Cancer 83: 1559-1564.
20. Steensel-Moll HA, Valkenburg HA, Vandenbroucke JP, van Zanen GE (1985) Are maternal fertility problems related to childhood leukaemia? Int J Epidemiol 14: 555-559.
21. Cnattingius S, Zack MM, Ekbom A, et al. (1995) Prenatal and neonatal risk factors for childhood lymphatic leukemia. J Natl Cancer Inst 87: 908-914.
22. Hasle H, Clemmensen IH, Mikkelsen M (2000) Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 355: 165-169.
23. Nishi M, Miyake H, Takeda T, Hatae Y (2000) Congenital malformations and childhood cancer. Med Pediatr Oncol 34: 250-254.
24. Altmann AE, Halliday JL, Giles GG (1998) Associations between congenital malformations and childhood cancer. A register-based case-control study. Br J Cancer 78: 1244-1249.
25. Mertens AC, Wen W, Davies SM, et al. (1998) Congenital abnormalities in children with acute leukemia: a report from the Children's Cancer Group. J Pediatr 133: 617-623.
26. Ferguson LR, Ford JH (1997) Overlap between mutagens and teratogens. Mutat Res 396: 1-8.
27. Health Canada (2002) Congenital anomalies in Canada - A perinatal health report, 2002. Ottawa, Minister of Public Works and Government Services Canada.
28. Christensen B, Rosenblatt DS (1995) Effects of folate deficiency on embryonic development. Baillieres Clin Haematol 8: 617-637.
29. Thompson JR, Gerald PF, Willoughby ML, Armstrong BK (2001) Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet 358: 1935-1940.
30. Infante-Rivard C, Olson E, Jacques L, Ayotte P (2001) Drinking water contaminants and childhood leukemia. Epidemiology 12: 13-19.
31. Koren G, Pastuszak A, Ito S (2001) Drugs in pregnancy. In: Koren G, ed. Maternal-Fetal Toxicology: A Clinician's Guide. New York: Marcel-Dekker.
32. Schaefer C (2001) Drugs During Pregnancy and Lactation. Amsterdam: Elsevier.
33. Dolovich LR, Addis A, Vaillancourt JM, Power JD, Koren G, Einarson TR (1998) Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ 317: 839-843.
34. Nulman I, Atanackovic G, Koren G (2001) Teratogenic drugs and chemicals in humans. In: Koren G, ed. Maternal-Fetal Toxicology: A Clinician's Guide. New York: Marcel Dekker.
35. Magee LA, Mazzotta P, Koren G (2002) Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). Am J Obstet Gynecol 186: S256-S261.
36. Matalon S, Schechtman S, Goldzweig G, Ornoy A (2002) The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol 16: 9-17.
37. Arpino C, Brescianini S, Robert E, et al. (2000) Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE). Epilepsia 41: 1436-1443.
38. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. (2000) Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62: 385-392.
39. Nahas G, Latour C (1992) The human toxicity of marijuana. Med J Aust. 156: 495-497.
40. Nora JJ, Nora AH, Blu J, et al. (1978) Exogenous progestogen and estrogen implicated in birth defects. JAMA 240: 837-843.
41. Preston-Martin S (1989) Epidemiological studies of perinatal carcinogenesis. IARC Sci Publ 289-314.
42. Dickson J (1977) Congenital deformites associated with Bendectin. Can Med Assoc J 117: 721.
43. Raman-Wilms L, Tseng AL, Wighardt S, Einarson TR, Koren G (1995) Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis. Obstet Gynecol 85: 141-149.
44. Wilson RD, Davies G, Desilets, V et al. (2003) The use of folic Acid for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 25: 959-973.
45. Pui CH, Kane JR, Crist WM (1995) Biology and treatment of infant leukemias. Leukemia 9: 762-769.
46. Infante-Rivard C (2003) Hospital or population controls for case-control studies of severe childhood diseases? Am J Epidemiol 157: 176-182.
47. Infante-Rivard C, Jacques L (2000) Empirical study of parental recall bias. Am J Epidemiol 152: 480-486.
48. Infante-Rivard C, Krajinovic M, Labuda D, Sinnett D (2002) Childhood acute lymphoblastic leukemia associated with parental alcohol consumption and polymorphisms of carcinogen-metabolizing genes. Epidemiology 13: 277-281.
49. Infante-Rivard C, Amre D, Sinnett D (2002) GSTT1 and CYP2E1 polymorphisms and trihalomethanes in drinking water: effect on childhood leukemia. Environ Health Perspect 110: 591-593.
50. Infante-Rivard C, Krajinovic M, Labuda D, Sinnett D (2000) Parental smoking, CYP1A1 genetic polymorphisms and childhood leukemia (Quebec, Canada). Cancer Causes Control 11: 547-553.